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Genome-wide epigenomic maps have revealed millions of putative enhancers and promoters,
but experimental validation of their function and high-resolution dissection of their driver
nucleotides remain limited. Here, we present HiDRA (High-resolution Dissection of
Regulatory Activity), a combined experimental and computational method for high-resolution
genome-wide testing and dissection of putative regulatory regions. We test ~7
million accessible DNA fragments in a single experiment, by coupling accessible chromatin
extraction with self-transcribing episomal reporters (ATAC-STARR-seq). By design, frag-
ments are highly overlapping in densely-sampled accessible regions, enabling us to pinpoint
driver regulatory nucleotides by exploiting differences in activity between partially-
overlapping fragments using a machine learning model (SHARPR-RE). In GM12878 lym-
phoblastoid cells, we ﬁnd ~65,000 regions showing enhancer function, and pinpoint ~13,000
high-resolution driver elements. These are enriched for regulatory motifs, evolutionarily-
conserved nucleotides, and disease-associated genetic variants from genome-wide associa-
tion studies. Overall, HiDRA provides a high-throughput, high-resolution approach for
dissecting regulatory regions and driver nucleotides.
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Precise spatiotemporal control of gene expression is achievedby the interplay between non-coding regulatory elements,including distal enhancers and proximal promoters, and the
transcriptional regulators they help recruit or repel, thus mod-
ulating the expression of nearby genes1–3. Unlike protein-coding
genes, which can be readily identiﬁed by their sequence properties
and evolutionary signatures, gene-regulatory elements lack highly
predictive sequence patterns and show only modest evolutionary
conservation at the nucleotide level1,4. Thus, systematic recog-
nition of gene-regulatory elements has relied on mapping of their
epigenomic signatures, including DNA accessibility, histone
modiﬁcations, and DNA methylation5–7. For example, both
enhancers and promoters have high DNA accessibility and low
H3K27me3, but distal enhancers show relatively higher H3K27ac
and H3K4me1 while promoters show relatively higher H3K9ac
and H3K4me38,9. However, many regions showing such epige-
nomic marks do not experimentally drive reporter gene expres-
sion, and some regions driving gene expression lack endogenous
signatures10–12. Moreover, epigenomic signatures are often low-
resolution, with important driver regulatory nucleotides com-
prising only a small subset of the larger regions showing epige-
nomic signatures13.
Experimental dissection of enhancer and promoter regions has
been traditionally expensive, laborious, low-throughput, and low-
resolution, lacking the resolution to pinpoint individual reg-
ulatory driver nucleotides without recourse to extensive muta-
genesis. Several recent high-throughput reporter assays for
enhancer function enable testing of thousands of distinct DNA
sequences simultaneously, by cloning variable DNA fragments
into common reporter constructs, and using high-throughput
sequencing to quantify fragment activity. Synthesis-based
approaches (e.g., MPRA14, CRE-seq15) use oligonucleotide
synthesis technology to generate elements and coupled barcodes.
Genome-fragmentation approaches (e.g., STARR-seq16, Cap-
STARR-seq17,18, ChIP-STARR19) use DNA fragments collected
or captured from genomic DNA. For synthesis-based approaches,
technical limitations of oligonucleotide synthesis technology
restrict the tested DNA fragment lengths to 130–230 nucleotides
(nt), and the number of tested constructs to
100,000–200,000 sequences per array. For genome-fragmentation
approaches, random fragmentation of the entire genome results
in only shallow coverage of regulatory elements, while synthesis-
based capture is limited in the number of regions interrogated
due to its reliance on oligonucleotide synthesis, and ChIP-based
capture is limited in only one or few transcription factors at a
time. To recognize driver nucleotides within tested regions,
synthesis-based approaches have used systematic mutagenesis20
or tiling at regularly-spaced intervals13, but both require synthesis
of many constructs for ﬁne-mapping each region, thus reducing
the number of regions that can be dissected at high resolution.
Here, we present High-resolution Dissection of Regulatory
Activity (HiDRA), a method for high-resolution inference of
transcriptional regulatory activity across all accessible regions of
the genome. HiDRA overcomes some limitations of previous
technologies and combine their advantages, enabling high-
throughput and high-resolution inference of regulatory activity.
Brieﬂy, we ﬁrst extract accessible DNA regions using ATAC-
seq21, size-select for constructs 150–500 nt long, and incorporate
them in self-reporting episomal constructs (ATAC-STARR-seq),
by insertion in the 3′ untranslated region (3′ UTR) of reporter
genes, thus enabling them to drive their own transcription and
serve as their own barcodes, providing a quantitative readout of
their activity. We then exploit the dense sampling of accessible
regions and the partially-overlapping nature of tested fragments
for high-resolution inferences using a machine learning approach
(SHARPR-RE). Our approach overcomes the construct-length
and region-count limitations of synthesis-based technologies at
substantially lower cost, and our ATAC-based selection of open
chromatin regions concentrates the signal on likely regulatory
regions and enables high-resolution inferences. Altogether, in a
single experiment we test millions of enhancer constructs of
comparable length to low-throughput studies while achieving the
high-resolution dissection of systematic perturbation studies. We
apply HiDRA to infer genome-wide regulatory activity across ~7
million DNA fragments preferentially selected from accessible
chromatin in the GM12878 lymphoblastoid cell line, resulting
in ~65,000 discrete genomic regions showing signiﬁcant reg-
ulatory function. These are enriched for endogenous active his-
tone marks (including H3K9ac, H3K27ac), regulatory sequence
motifs, and regions bound by immune regulators. Our selection
approach resulted in highly-overlapping fragments (~32,000
regions covered by 10+ unique fragments, ~12,500 by 20+
fragments), enabling us to pinpoint “driver” regulatory nucleo-
tides that are critical for transcriptional enhancer activity. We
discover ~13,000 of these high-resolution driver elements, which
are enriched for regulatory motifs and evolutionarily conserved
nucleotides, and help predict causal genetic variants underlying
disease from genome-wide association studies. Overall, HiDRA
provides a general, scalable, and high-throughput approach for
the high-resolution experimental dissection of regulatory regions
and driver nucleotides in the context of human biology and
disease.
Results
HiDRA experimental method overview. HiDRA leverages the
selective fragmentation of genomic DNA at regions of open
chromatin to generate fragment libraries that densely cover
putative transcriptional regulatory elements. The experimental
component of HiDRA is the combination of ATAC-seq and
STARR-seq (i.e., ATAC-STARR-seq): fragments are enriched
from open chromatin and regulatory regions using ATAC-seq
(Assay for TransposaseAccessible Chromatin with high-
throughput sequencing) and subsequently cloned into the 3′
UTR of a reporter gene on the self-transcribing enhancer reporter
vector used in Self-Transcribing Active Regulatory Region
sequencing (STARR-seq)13,16,21. Fragments with transcriptional
regulatory activity promote self-transcription such that active
segments of DNA can be identiﬁed and quantiﬁed by
high–throughput RNA sequencing to produce a quantitative
readout of enhancer activity (Fig. 1a). Library construction can be
completed in 2–3 days and requires as few as 104–105 cells as
input starting material.
We constructed a HiDRA library with 9.7 million total unique
mapping fragments, of which 4 million had a frequency greater
than 0.1 reads per million (RPM; non-mitochondrial reads).
More than 99% of fragments had lengths between 169 nt and 477
nt (median: 337 nt), with the fragment length distribution
showing two peaks spaced by ~147 nt, corresponding to the
length of DNA wrapped around each nucleosome (blue bars,
Fig. 1b). In contrast to unbiased fragmentation of the genome,
our library has much higher efﬁciency for selectively targeting
accessible DNA regions that are more likely to play gene-
regulatory roles. Our HiDRA library covers 4486 predicted
enhancers and 9631 predicted promoters (“Active Transcription
Start Site (TSS)” state5,6,14) with more than 10 unique fragments
(Fig. 1c, colored lines), a ~130-fold and ~210-fold enrichment
compared with 35 enhancer and 46 promoter regions expected to
be covered by chance at the same coverage. This indicates that
HiDRA library construction successfully targets predicted
regulatory regions rather than randomly fragmenting the
genome. Even among enhancer and promoter regions and
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Fig. 1 Overview of HiDRA. a Cells with the desired genotype and open chormatin patterns are selected for library construction. Tn5 transposase is used to
preferentially fragment genomic DNA at regions of open chromatin. Fragments are then size-selected on an agarose gel and mtDNA contamination is
removed by selective CRISPR-Cas9 degradation. The fragment library is ampliﬁed by PCR and cloned into an enhancer reporter vector. Gel image adapted
from Buenrostro et al.21. Fragments are cloned into the STARR-seq vector backbone, introduced into target cells (which can differ from cells used to
construct the library), and RNA is collected and sequenced. After data processing, the activity of partially-overlapping fragments is compared to identify
driver nucleotides using the SHARPR-RE algorithm. b Size distribution of HiDRA library fragments (blue) and tiled regions (green). Bimodal shape for
library fragment sizes is due to Tn5 preference to cut adjacent to nucleosomes. Fragment bin size= 20 nt, region bin size= 50 nt. c Number of
ChromHMM-predicted active enhancer, active TSS and ATAC-seq peaks covered by multiple unique HiDRA fragments. d HiDRA plasmid library
recapitulates the genomic coverage of a conventional ATAC-seq experiment
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ATAC-seq peaks, those with higher expected activity are
preferentially selected by HiDRA, as they show higher accessi-
bility and are thus more likely to be cloned in our library and
tested by our episomal reporters (Supplementary Fig. 1).
Our cloning strategy is speciﬁcally designed to densely
sample regulatory regions, in order to enable high-resolution
inference of regulatory activity from highly overlapping
fragments. Indeed, we found up to 370 unique fragments per
region in our HiDRA libraries, with ~32,000 genomic intervals
containing at least 10 overlapping fragments (“tiled regions”,
green bars, Fig. 1b) and ~2750 containing at least 50 fragments,
compared with 180 and 0 that would be expected by randomly
selected fragments, respectively. In addition to clustering of
tested fragments within the same region, high-resolution
inference relies on partially-overlapping rather than fully-
overlapping fragments, which requires a random fragmentation
pattern. Indeed, the Tn5 transposase we used here inserts
randomly into the genome, and indeed the resulting DNA
fragments provide a dense sampling of start and end positions
that mirrors the peaks of ATAC-seq experiments (Fig. 1d),
indicating that accessible regions most likely to show regulatory
activity will have both higher representation in our libraries,
and also more starting and ending positions that can help
identify driver nucleotides.
Identiﬁcation of DNA fragments with regulatory activity. To
evaluate the ability of each cloned DNA fragment to promote
gene expression, we transfected our HiDRA library into
GM12878 lymphoblastoid cells, collected RNA 24 h post-trans-
fection, and measured the abundance of transcribed fragments by
high-throughput RNA sequencing. We carried out ﬁve replicate
transfection experiments from the same plasmid library, each
into ~120 million cells, and we observed a high degree of cor-
relation in the RNA counts between replicates (0.95 Pearson
correlation on average for fragments ≥ 1 RPM; 0.76 for ≥ 0.1
RPM; Supplementary Fig. 2). To quantify the regulatory activity
of tested elements, we compared the number of RNA reads
obtained for a fragment (corresponding to the expression level of
the reporter gene, as the constructs are self-transcribing), relative
to representation of that fragment in the non-transfected input
plasmid library (thus normalizing the differential abundance of
each fragment in our library). We observed a substantial number
of fragments that are more prevalent in RNA than DNA, indi-
cating capability of many HiDRA fragments to drive reporter
gene expression (Fig. 2a).
Given the intentionally high initial complexity of our HiDRA
library, many fragments will be sequenced with a relatively low
depth of coverage. We therefore grouped fragments with a 75%
reciprocal overlap to boost the read coverage of genomic regions
and increase statistical power. This yielded 7.1 million unique
“fragment groups” generated from merging 9.7 million HiDRA
fragments. In total, we identiﬁed 95,481 fragment groups that
promote reporter gene expression at an FDR cutoff of 0.05, which
we will refer to as “active HiDRA fragments” (Fig. 2a, red dots,
see Methods). These 95,481 active HiDRA fragments are located
within 66,254 unique genomic intervals that we subsequently
refer to as “active HiDRA regions” (Supplementary Data 1).
Active HiDRA fragments showed a wide range of input DNA
levels in our plasmid library, indicating that regulatory function
and DNA accessibility rely on complementary sequence signals,
and that DNA accessibility alone is not sufﬁcient to predict
episomal regulatory activity. We also found that active HiDRA
regions are predominantly distal to annotated transcription start
sites (TSSs) (Fig. 2b), validating the utility of HiDRA for
pinpointing distal regulatory regions that are particularly
challenging to identify.
As proof-of-concept that HiDRA is capable of identifying true
enhancer elements, we examined the well-studied immunoglo-
bulin heavy-chain enhancer within the intron of the immuno-
globulin heavy constant epsilon (IGHE) gene22. We observed that
the peak of HiDRA activity is centered precisely within the region
previously identiﬁed as driving enhancer activity in low-
throughput luciferase assays (Fig. 2c). To assess the quantitative
accuracy of HiDRA relative to luciferase assays, we compared
active HiDRA regions and luciferase results across 21 putative
enhancers predicted and tested independently by Huang et al.23.
We found a 0.88 Pearson correlation between measured luciferase
activity and HiDRA activity, conﬁrming the accuracy and
quantitative nature of our high-throughput approach (Fig. 2d).
A visualization of 14 luciferase-tested enhancers in the serine/
threonine kinase NEK6 locus shows a strong correspondence
between luciferase assay results and HiDRA active regions
(Fig. 2e).
HiDRA elements are enriched in promoters and enhancers. We
surveyed the 95,481 active HiDRA fragments identiﬁed in
GM12878 to assess shared common genomic or epigenomic
characteristics. In comparison with the set of all HiDRA frag-
ments tested, active fragments were eight times more likely to
overlap regions annotated as active promoter chromatin states by
ChromHMM based on the presence of H3K4me3 and H3K27ac,
and ﬁve times more likely to overlap annotated Active Enhancer
chromatin states, marked by H3K4me1 and H3K27ac (Fig. 3a).
By contrast, weak enhancer chromatin states marked by
H3K4me1 and absence of H3K27ac have substantially weaker
enrichment (1.7-fold) within active HiDRA fragments than active
enhancers, consistent with previous literature indicating that the
presence of H3K27ac correlates with greater expression of nearby
genes (Fig. 3b). Overall, 35% of all predicted active promoters
(8355 regions) and 16% of all predicted active enhancers (5276
regions) overlapped at least one active HiDRA fragment.
In addition to active promoter and active enhancer chromatin
states, the “TSS Flanking Upstream” chromatin state showed
strong enrichment for active HiDRA fragments (7.3-fold higher
than expected from the input library). This chromatin state is
deﬁned by the presence of both promoter and enhancer histone
marks H3K4me1, H3K4me3, and H3K27ac, and was named “TSS
Flanking” due its depletion at exactly the TSS position, but its
enrichment 400 nt-1kb upstream of annotated transcription start
sites7. However, 64% of its occurrences are > 2 kb from the
nearest transcription start site, suggesting that a portion of
genomic regions annotated as “TSS Flanking Upstream” may
function biologically as distal enhancers (Supplementary Fig. 3).
When we computed enrichment of chromatin states as a
function of HiDRA activity strength, we found a linear
quantitative relationship for HiDRA activity levels up to ~2.5-
fold RNA/DNA ratios, with increasing activity showing increas-
ing chromatin state enrichment for both promoter and enhancer
chromatin states (Fig. 3b). Surprisingly, this enrichment stayed
constant thereafter for promoter regions, and increased modestly
for enhancer regions, ultimately surpassing the enrichment seen
for promoters. In fact, even though promoter chromatin states
were more enriched at intermediate HiDRA activity levels,
enhancer chromatin states were the most enriched at the highest
HiDRA activity levels (p= 9.3 × 10–102, Mann–Whitney U test,
Supplementary Fig. 4a), suggesting that enhancer elements have a
greater dynamic range of regulatory activity potential, which has
implications for the regulatory architecture of genes.
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Surprisingly, fragments from heterochromatin-associated chro-
matin states showed a modest enrichment in active elements,
indicating that DNA kept in an endogenous heterochromatic state
may contain regulatory signals that become active once taken
outside their repressive endogenous chromosomal context. The
ZNF/repeats-associated chromatin state (marked by H3K36me3
and H3K9me3) showed a modest enrichment for lower HiDRA
activity levels, but continued to increase linearly even at the
highest activity levels, possibly due to active repetitive elements, as
we discuss below. In contrast, quiescent and polycomb-repressed
chromatin states showed a two-fold relative depletion for HiDRA
active elements, accounting for the enrichments found in other
states. The depletion of polycomb-repressed chromatin states may
also reﬂect polycomb repression on the episomal plasmid.
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We also studied the enrichment of HiDRA regions for individual
histone marks proﬁled by the ENCODE project in GM128787.
Active promoter- and active-enhancer-associated acetylation marks
H3K9ac and H3K27ac, histone turnover-associated H2A.Z, pro-
moter- and enhancer-associated H3K4me3 and H3K4me1, and
DNase I accessible chromatin were the most enriched individual
marks within active HiDRA regions, while polycomb-repression-
associated H3K27me3, heterochromatin-associated H3K9me3, and
transcription-associated H3K36me3 were the least enriched com-
pared with the input library (Supplementary Fig. 5).
As these elements are tested outside their endogenous
chromatin context, we expect that they drive reporter gene
transcription by recruiting transcriptional regulators in a
sequence-speciﬁc way, and we sought to gain insights into the
recruited factors. We calculated the overrepresentation of 651
transcription factor sequence motifs assembled by ENCODE in
active HiDRA regions, and found enrichment for many distinct
motifs for immune transcription factors (Supplementary Fig. 4b),
including IRF, NFKB1, and RELA, corresponding to transcrip-
tional regulators known to function in GM12878 compared with
other human cell lines. The motifs enriched in promoter
chromatin states were largely distinct from those enriched in
enhancer chromatin states, highlighting the differential regulatory
control of the two types of regions (Supplementary Figs. 4b–d).
High-activity fragments showed distinct motif composition, and
were enriched for GM12878 regulators including NF-kB
(Supplementary Figs. 4e, f). These differences in motif content
indicate that the two types of regions recruit different sets of
transcriptional regulators both in their endogenous context and
in our episomal assays, consistent with their distinct endogenous
chromatin state and their distinct properties in our HiDRA
assays.
Regulatory activity outside promoters and enhancers. Even
though HiDRA active regions were most enriched for enhancer
and promoter states, they were not exclusive to them. In fact,
consistent with recent studies24,25, approximately half of active
HiDRA regions (52%) showed endogenous epigenomic signatures
characteristic of repressed and inactive chromatin states, includ-
ing quiescent, repressed polycomb, weak repressed polycomb,
and heterochromatin.
As active chromatin states were deﬁned based on the proﬁling
of only a subset of known chromatin marks in GM12878, we
reasoned that perhaps other marks may be marking these regions
active, but that they were perhaps not proﬁled in GM12878 and
thus missed by the reference genome annotations. For example, a
recent study identiﬁed subclasses of active enhancer elements
marked with H3K122ac or H3K64ac but not H3K27ac12. While
these marks were not proﬁled in GM12878, inactive chromatin
states that showed HiDRA activity were 8-fold to 13-fold more
likely to be bound by transcription factors in ChIP-seq
experiments in GM12878 than inactive chromatin states that
lacked HiDRA activity (Fig. 3d), indicating that our assays can
successfully recover active regions even outside active chromatin
states, and highlighting the importance of our unbiased survey of
open chromatin regions regardless of their endogenous chroma-
tin marks.
As both high-throughput and low-throughput episomal
assays test regions outside their endogenous chromatin context,
we reasoned that some active HiDRA regions with inactive
chromatin signatures may reﬂect endogenously inactive regions
that become active when removed from the inﬂuence of nearby
repressive effects. We reasoned that these regions would
contain sequence motifs of TFs active in GM12878, but that
these sequence motifs would be less likely to be bound in their
endogenous chromatin context, compared with motifs in active
states. Indeed, we found that active HiDRA regions from
endogenously inactive chromatin states showed similar enrich-
ments in regulatory motif sequence coverage to that of
enhancer and promoter chromatin states (Fig. 3c), but
substantial differences in their endogenous TF binding (Fig. 3d),
consistent with endogenous repression due to their genomic
context. These regions were also ~30% more likely to be
active in another human tissue, compared with HiDRA-
inactive regions (Supplementary Fig. 6), consistent with
cell type-speciﬁc repression in their endogenous chromatin
context.
In addition to the presence of regulatory motifs for known
regulators active in GM12878, we sought additional driver
elements that may be responsible for the episomal activity of
endogenously inactive regions. In particular, we considered the
presence of long-terminal-repeat (LTR) retrotransposons, which
have been previously shown to have regulatory activity potential
and were enriched in the set of all active HiDRA regions
unlike other repetitive elements in the genome (Supplementary
Fig. 7a)13,26. Indeed, we found that active HiDRA regions from
endogenously inactive regions showed substantial enrichment for
LTR retrotransposons. In fact, quiescent and heterochromatin
states were more enriched for LTR retrotransposons than either
Enhancer or Promoter chromatin states (Supplementary Fig. 7b).
These regions are endogenously inactive despite their seeming
regulatory activity potential, likely due to the effect of repressive
chromatin in their endogenous loci. As LTRs are motif-rich and
often act as the substrate for recently evolved enhancers, these
endogenously inactive but episomally-active HiDRA regions may
represent a reservoir for the emergence of new regulatory
elements2.
High-resolution mapping of regulatory activity with HiDRA.
We sought to exploit the highly overlapping nature of tested
HiDRA fragments to increase the resolution of regulatory infer-
ences by exploiting subtle differences between neighboring frag-
ments that only overlap partially. As an example, we considered a
3 kb region on chromosome 7 that is covered by 134 HiDRA
fragments with distinct start and end positions. When we
examine every fragment in this region, we observed that frag-
ments overlapping a known RUNX3 motif showed substantially
higher regulatory activity (Fig. 4a). This motif is bound by the
RUNX3 protein in GM12878 cells and shows increased evolu-
tionary conservation (Fig. 4a)7. These properties suggest that the
driver regulatory nucleotides within this region are tightly con-
centrated surrounding the RUNX3 motif, and that on the global
level the differential activity of HiDRA-tested segments should
enable us to systematically discover these driver nucleotides in an
unbiased way based on the relative activity of fragments that do
or do not overlap them.
As part of our development of Sharpr-MPRA13, we had
previously developed the SHARPR algorithm (Systematic High-
resolution Activation and Repression Prediction from Reporter
assays), a graphical probabilistic model that inferred high-
resolution activity from MPRA tiling experiments by reasoning
about the differential activity of partially-overlapping micro-
array spots. Intuitively, SHARPR allowed us to transform
measurements from the 145-bp resolution of individually tested
tiles to the 5-bp resolution of the offset between consecutive
tiles. The SHARPR algorithm relies on synthesized oligos that
uniformly tile regions at regularly spaced intervals, and thus is
not applicable for the random fragmentation nature of HiDRA
experiments where both the length and the spacing of
neighboring fragments can vary. To address this challenge, we
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developed a new algorithm, SHARPR-RE (for SHARPR with
Random Endpoints), which estimates regulatory scores under-
lying any set of randomly positioned and variable-length
segments, by appropriately scaling the segments by their
varying lengths, and enabling inferences at variable-length
offsets between them (Supplementary Methods).
Applying the SHARPR-RE algorithm to the RUNX3 example
above, we found that the 3 kb region was narrowed down to a
single “driver” element of 27 nt (Fig. 4a). These captured the
known RUNX3 motif shown experimentally by ChIP-seq to be
bound by the RUNX3 regulator in GM128787, and also the
independently determined high-resolution region of evolutionary
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conservation, even though neither line of evidence was used in
our inferences.
Across all ~32,000 “tiled regions” that are covered by at least 10
unique HiDRA fragments (Fig. 1b, Supplementary Fig. 8),
SHARPR-RE predicted ~13,000 driver elements of median length
52 nt, using a regional family-wise error rate of 5% (Fig. 4b, see
Supplementary Methods and Supplementary Data 2 and 3). The
resolution with which driver elements could be resolved increased
with the number of unique HiDRA elements spanning a tiled
region, reﬂecting both the increased number of breakpoints in
densely tiled regions, and the increased discovery power afforded
by the SHARPR-RE algorithm. Regions tiled by 40 or more
fragments showed ~20 nt resolution (Supplementary Fig. 9).
Regions tiled by fewer fragments (10–20) showed lower
resolution (~50 nt), but resolution only increased to ~18 nt with
higher fragment density, suggesting the minimum size of driver
elements detectable by the HiDRA assay that result in regulatory
activity is only slightly longer than individual regulatory motifs.
Similar to active HiDRA regions, driver elements were also
mostly distal from annotated TSS regions, and were preferentially
found in endogenously active chromatin states (active promoters,
TSS ﬂanking, and active enhancer regions, Supplementary
Fig. 10).
Compared with a background of all tiled regions, which are
speciﬁcally enriched for GM12878 regulatory regions, we found
that predicted driver nucleotides were signiﬁcantly more enriched
for regulatory motifs than shufﬂed controls (obtained by
randomly shufﬂing driver element positions within the same set
of tiled regions with at least 10 unique HiDRA fragments). The
enriched motifs consisted of regulators known to be active in
GM12878, including several critical B-cell and immune tran-
scription factor including NF-kB and the IRF family (Fig. 4c). A
total of 98 motifs were enriched in driver elements (FDR < 0.05
vs. random shufﬂing of driver elements in tiled regions, see
Methods), clustering into several distinct groups with little
overlap between groups, suggesting a wide range of distinct
transcription factors act to regulate GM12878 gene expression
(Fig. 4d). We also found that driver nucleotides are signiﬁcantly
more likely to be evolutionarily conserved across vertebrates than
randomly shufﬂed controls in tiled regions (Fig. 4e), with ~1080
driver elements overlapping conserved regions, compared to only
~650 expected by random shufﬂing of driver elements within
tiled regions (p= 2.23 × 10–73). Driver elements are also more
evolutionarily conserved than equally sized segments residing
directly upstream or downstream (Supplementary Fig. 11a),
supporting the biological importance of the high-resolution
inferences.
We also validated our high-resolution predictions using an
independent high-resolution experimental method based on
MPRA array synthesis and high-resolution tiling (Sharpr-
MPRA13). As the original SHARPR algorithm does not include
the functionality to call discrete driver elements, we compared
Sharpr-MPRA activity scores within driver elements identiﬁed in
this study compared with equally sized segments shifted upstream
and downstream. We found that HiDRA driver elements are
much more likely to show Sharpr-MPRA activity than these
shifted segments. Sharpr-MPRA activity scores peaked for
HiDRA driver elements, and were lower in ﬂanking regions
(256 regions tested in both HepG2 and K562, Supplementary
Fig. 11b), supporting the functional importance of HiDRA driver
nucleotides (Supplementary Fig. 11b, left panels). The agreement
was stronger for Sharpr-MPRA scores in K562 than HepG2 (Fig.
S11b3), consistent with its higher similarity to GM12878.
Speciﬁcally distinguishing accessible DNA sites based on their
motif content (and thus the trans-acting TFs predicted to target
them), we found that predicted targets of K562 and HepG2 TFs
that are also expressed in GM12878 showed even higher Sharpr-
MPRA scores, whereas targets of TFs that are not expressed in
GM12878 showed nearly complete loss of any enrichment signal
(Supplementary Fig. 11b, right panels), thus providing a
mechanistic explanation for their similarity in activity.
We also evaluated whether genetic variants in predicted driver
nucleotides are more likely to result in differential activity
between the two alleles, compared with other genetic variants. We
used the results of an independent experimental study that
quantiﬁed allelic enhancer activity for 4335 single-nucleotide
polymorphisms (SNPs) across the genome27, of which 24 overlap
driver elements identiﬁed by our assay. Genetic variants inside
driver elements indeed showed signiﬁcantly stronger allelic skews
compared with all variants tested by MPRA (p= 1.62 × 10–4,
Mann–Whitney U test), and also compared with all tested
variants inside HiDRA-tiled regions but outside driver elements
(p= 9.20 × 10−4, Mann–Whitney U test) (Fig. 4f), supporting the
functional importance of our predictions, and the high-resolution
nature of our driver elements.
Taken together, these results indicate that our high-resolution
inferences are biologically meaningful and can help pinpoint
driver nucleotides among larger regions.
Characterization of GWAS SNPs affecting enhancer activity.
We next sought to use our predicted active regions and driver
nucleotides to gain insights into non-coding variation, as past
work has demonstrated that disease-associated variants are pre-
ferentially localized to regulatory elements4,28,29. We studied the
overlap between genetic variants associated with immune dis-
orders and our high-resolution predicted driver nucleotides. Even
though driver nucleotides only cover 0.032% of the genome, we
found 12 cases where they overlap ﬁne-mapped SNPs associated
with 21 immune-related traits30 predicted to be causal (~5
expected by chance inside tiled regions, p= 0.012 vs. random
shufﬂing of driver elements within tiled regions, Fig. 5a). For
example, we predict a 76-nt driver element overlapping
rs12946510 in the IKZF3 locus associated with multiple sclerosis
in a tiled region of 3 kb (Fig. 5b), suggesting this may be the
causal variant. The SNP overlaps a 76-nt driver element that
contains a RUNX3 motif and a RELA motif, both bound by the
respective TFs in GM128787. Indeed, rs12946510 is predicted to
be causal based on genetic ﬁne-mapping30, with a posterior
probability of 0.314 of being causal with the next strongest signal
showing only 0.067 posterior probability. rs12946510 is also an
eQTL for the nearby IKZF3 gene30,31, and was recently shown to
disrupt enhancer activity for the surrounding 279-nt region using
a luciferase reporter assay32, consistent with our prediction that
rs12946510 is a causal SNP.
To recognize regions that showed differential activity between
risk and non-risk alleles of common genetic variants, we ﬁrst
inferred the genotype of all RNA fragments proﬁled. As HiDRA is
a sequencing-based assay, where the expression of reporter genes
is quantiﬁed based on the number of sequencing reads, allele-
speciﬁc differences in HiDRA activity between risk and non-risk
haplotypes should be detectable in principle by using hetero-
zygous positions to distinguish reads coming from the paternal or
the maternal allele. In practice, however, HiDRA fragments are
much longer (~337 median length) than the typical sequencing
reads we used for quantiﬁcation (37 nt, paired end), and thus 78%
of genetic variants will not be covered by our sequencing reads (if
they fall in the inner ~260 nt not captured by our paired-end
sequencing). To overcome this limitation and to determine allele-
speciﬁc activity scores for all our fragments, we used low-depth
re-sequencing of our input library using long reads, thus revealing
the genotype associated with each start/end position in our library
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(Fig. 6a). We augmented this information with 4-nt random i7
barcodes that were added by PCR during the initial HiDRA
library construction, thus ensuring that the [start, end, i7] triplet
is almost guaranteed to be unique, by resolving the cases where
both start and end positions are identical between paternal and
maternal alleles. This strategy enabled us to resolve the genotype
of all previously quantiﬁed HiDRA fragments without having to
sequence both the plasmid and RNA libraries to full length at
high depth, which would be too costly.
In a proof-of-concept analysis to assess the ability of HiDRA to
detect allelic activity, we applied this approach systematically to
all heterozygous positions known in the genotyped GM12878 cell
lines. We found ~180,000 heterozygous SNPs that were
represented by at least one HiDRA fragment at either allele in
our library. Detection of allelic activity with random fragmenta-
tion is subject to confounders, as fragments carrying the maternal
or paternal allele of a SNP may also differ at their start and end
positions, which may result in activity differences independent of
SNP effects (Supplementary Fig. 12). To minimize such effects,
we only compared fragments with 90% mutual overlap, and with
driver elements at least 25 nt from fragment ends. Additionally,
statistical power to detect allelic differences may be limited for
many SNPs. We also only consider SNPs that have >20 read
coverage for both fragments (reference and non-reference alleles).
In total, ~16,000 SNPs remained after applying these three ﬁlters.
At an uncorrected nominal p-value cutoff of 0.05, we found 880
“allelic” HiDRA SNPs where paternal and maternal alleles
showed differences in activity, 25 of which had a corrected
FDR < 0.1 (beta-binomial model33, Supplementary Data 4).
The corresponding SNPs in these 880 allelic HiDRA regions
were more frequently found in HiDRA active regions and more
frequently predicted to have strong regulatory effects in open
chromatin regions by an independent study34 (Fig. 6b, c),
suggesting they are biologically meaningful. As an example, we
found that rs2382817, a SNP associated with inﬂammatory bowel
disease31 (GWAS p= 1.13 × 10–13), shows differential HiDRA
activity between paternal and maternal alleles. The risk allele
shows increased regulatory activity upstream of a HiDRA-
annotated active region (nominal p= 8.7 × 10–4, FDR= 0.25,
p-values from QuASAR-MPRA, Fig. 6d, e), illustrating the
possibility of using HiDRA to detect SNPs with allelic effects
on regulatory activity.
These results indicate that HiDRA can help shed light on
disease-associated variants, by either narrowing down the set of
candidate causal SNPs using our high-resolution driver nucleo-
tide inferences, or by directly observing differential activity
between risk and non-risk alleles using allele-speciﬁc activity
inferences.
Discussion
In this paper, we introduced a high-throughput experimental
assay, HiDRA, for testing transcriptional regulatory activity
across millions of DNA fragments, and for inferring high-
resolution driver elements within them. In the experimental
component of HiDRA, we capture regions of open chromatin,
size selecting them, and inserting them downstream of tran-
scription start in an episomal reporter construct, thus driving
their own transcription and serving as their own barcodes
(ATAC-STARR-seq). By concentrating the signal on open-
chromatin regions, HiDRA enables high-resolution inference of
driver nucleotides within these regions using a machine-learning
model (SHARPR-RE), by exploiting subtle differences in the
reporter activity driven by partially overlapping tested fragments.
We refer to the combined SHARPR-RE-ATAC-STARR-seq
method as the “High-resolution Dissection of Regulatory Activ-
ity”, or HiDRA. By capturing putative regulatory regions directly
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from open chromatin regions, HiDRA has the advantage of
foregoing oligonucleotide synthesis, and thus enabling testing of
much longer fragments, and testing many more regions in a
single experiment.
We applied HiDRA on the GM12878 lymphoblastoid cell line,
revealing a global map of regulatory elements and their sequence-
driven effects on transcription. We showed that HiDRA provides
a quantitative assay with strong sensitivity and speciﬁcity, com-
pared to low-throughput luciferase assays. We showed that
fragments with the strongest activity show endogenous promoter
and enhancer signatures, contain motifs for immune transcrip-
tion factors, and show in vivo binding by immune regulators. We
also showed that driver nucleotides inferred by our high-
resolution mapping are enriched for evolutionarily-conserved
regions, known regulatory motifs for immune regulators, and for
genetic variants associated with immune traits. We also showed
that long-read resequencing of the HiDRA library can distinguish
allele-speciﬁc activity of risk vs. non-risk fragments derived from
heterozygous loci associated with disease, enabling directionality-
of-effect inference and providing mechanistic insights on disease
loci.
Currently, the only other method that enables the high-
resolution dissection of thousands of putative regulatory regions
is Sharpr-MPRA13. Both Sharpr-MPRA and HiDRA seek to map
regulatory regions at high resolution, but they differ in several key
respects: Sharpr-MPRA selects regions based on prior computa-
tional predictions, requiring microarray-based synthesis. This
in vitro synthesis step limits the number of nucleotides and
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regions tested by Sharpr-MPRA (4.6 Mb in 15,720 regions for
Sharpr-MPRA vs. 46.3 Mb in 31,813 regions for HiDRA).
Moreover, Sharpr-MPRA uses ﬁxed 5-bp increments (vs. random
increments for HiDRA, stemming from the transposase frag-
mentation pattern), 145-bp fragments (vs. random lengths for
HiDRA, 335-bp on average), and Sharpr-MPRA tests elements
upstream of the TSS using 3′ UTR barcodes (vs. testing elements
downstream, thus enabling them to serve as their own barcodes).
The ATAC-STARR-seq step in HiDRA has many beneﬁts
compared with regular STARR-seq without fragment selection.
ATAC-STARR-seq preferentially tests the activity of fragments
derived from open chromatin, and the HiDRA library we
developed achieves 130–220X more highly covered regulatory
elements than random genome fragmentation (Fig. 1c). This
facilitates both higher conﬁdence discovery of regulatory ele-
ments, and the high-resolution dissection of regulatory elements
by comparing the relative activity of partially overlapping frag-
ments. This latter application using our newly developed
SHARPR-RE algorithm permits the genome-wide mapping of
high-resolution driver elements, and would not be possible with
regular STARR-seq unless extremely complex fragment libraries
are used (at least 15- or 20-fold more complex than this current
library). HiDRA can therefore be feasibly and readily applied
across a wide range of tissues for high-resolution mapping
without the limitations that regular STARR-seq would entail
(e.g., > 109 cells per tissue, and high depth of sequencing to
quantify a library with ~20-fold more fragments).
The HiDRA approach is general and can be readily adapted for
other applications. While we performed our study using ATAC
regions from the GM12878 cell line and re-transfection of con-
structs in the same cell line, the approach is applicable to any cell
type, and to combining of different source and target cells. For
example, libraries could be generated from limited patient tissue,
or a pool of multiple donors to increase heterozygous loci, and
subsequently transfected into a relevant immortalized cell line
that can be easily grown to high cell quantities. Here, we used
transfection to introduce episomal plasmid reporters, but lenti-
viral methods can be used in cell lines with lower transfection
efﬁciencies. We chose non-integrating episomal reporters to focus
more directly on sequence function independently of its broader
chromatin context, however the HiDRA approach can be used
with an integrating lentiviral vector to also incorporate the effect
of chromosomal context, with the understanding that previous
analyses used up to ~100 integration sites per tested element to
accurately quantify activity35. Moreover, integrating reporter
techniques can require cell sorting using ﬂuorescent reporter
activity, which limits the number of constructs that can be
tested36.
Several improvements are possible on the existing HiDRA
experimental approach. In addition to the minimal SCP1 pro-
moter, the STARR-seq vector has a second active promoter at the
bacterial ORI site, whose transcripts are both more abundant and
have stronger signal-to-noise ratios at regulatory elements25.
Thus, to improve detection of modestly-active enhancer elements,
future studies may forgo the SCP1 promoter altogether and utilize
the ORI site exclusively. Zabidi et al. previously demonstrated
that different promoters in Drosophila STARR-seq experiments
will uncover different classes of enhancer elements (e.g., devel-
opmental vs. housekeeping)37. Based on Muerdter et al., the
pSTARR-seq_human plasmid employed here drives transcrip-
tional initiation from two promoter elements: the SCP1 synthetic
core promoter and the bacterial plasmid origin of replication,
suggesting that the original pSTARR-seq_human plasmid may
identify more active enhancer elements than newer STARR-seq
plasmid backbones lacking SCP125. Future HiDRA studies can
also increase the diversity of promoter sequences tested to
improve the detection of subclasses of enhancer elements. In
addition, transfection can induce interferon response in some cell
types, which can alter the transcriptional landscape if they do not
already express interferon, as is the case for HeLa-S3 cells25. The
GM12878 cell line used here already expresses interferon-
stimulated genes such as IFIT1, ISG15, and IRF7, similarly to
other EBV-transformed lymphocyte lines, and thus interferon
response does not greatly alter the regulatory landscape. For other
cell lines, we recommend following the recommendation by
Muerdter et al. and inhibiting relevant IRF signaling kinases
during plasmid transfection25.
The HiDRA approach can also be speciﬁcally tuned for map-
ping differential allele activity in regulatory regions associated
with human disease SNPs from GWAS. At the library construc-
tion stage, capture probes can be used to further increase coverage
at known polymorphic SNPs of interest, thus increasing ﬁne-
mapping resolution, facilitating comparison of fragments with
alternate alleles but matching start and end positions, and
increasing statistical power to detect differential activity between
risk and non-risk alleles. To increase the number of heterozygous
sites, future studies can pool cells or tissue from multiple indi-
viduals, thus ensuring polymorphic representation of many
disease-associated loci. For cancer mutations and other somatic
mutations, HiDRA may also be applied to pools of tumor sam-
ples, or pools of disease tissue, to identify variants that alter
regulatory activity and gene expression38. For systematic muta-
genesis, HiDRA libraries can also processed to introduce new
mutations through error-prone PCR or introduction of mutagens
during ampliﬁcation.
We also envision modiﬁcations of the HiDRA assay presented
here for testing speciﬁc subsets of the genome. A modiﬁed
HiDRA assay may be used to enrich for fragments from active
regulatory regions, by coupling HiDRA with a fragment capture
technology similar to those used in Capture Hi-C to selectively
test a subset of enhancers or promoters at higher resolution while
retaining the advantages of having larger fragment sizes and high
library complexity39. To test regions associated with speciﬁc
chromatin states, capture could be performed using the output of
chromatin immunoprecipitation experiments (ChIP) using his-
tone modiﬁcations, thus preferentially sequencing genomic
regions that were also pulled down with ChIP. Finally, the
SHARPR-RE high-resolution mapping algorithm developed here
can be applied to perform high-resolution mapping of genomic
regions for high-complexity libraries with sufﬁcient fragment
density (e.g., testing of individual large regions using bacterial
artiﬁcial chromosome clones with “BAC-STARR-seq”16, or high-
resolution mapping of transcription factor binding sites with
ChIP-STARR-seq19). We envision that HiDRA and such mod-
iﬁed approaches can be used to quantify the transcriptional reg-
ulatory landscape of DNA sequences for a variety of tissues from
multiple organisms.
Methods
HiDRA library construction. We performed 16 ATAC-seq reactions on 50,000
GM12878 cells, each using a modiﬁed protocol based upon Buenrostro et al.21
(Supplementary Note 1). Initial steps of ATAC-seq (cell collection, lysis, and Tn5
digestion) followed the protocol in Buenrostro et al.21: each batch of 50,000 cells
was collected by spinning at 500 g for 5 min in a 4 °C cold room, washed with 50 µL
of 1X PBS, and resuspended in ATAC-seq lysis buffer (10 mM Tris-HCl, pH 7.4,
10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA−630); a pellet was collected by
spinning at 500 g for 10 min, and was resuspended in 25 µL of TD buffer (Illumina
#FC-121–1030), 2.5 µL Tn5 transposase (Illumina #FC-121–1030), and 22.5 µL of
dH2O; the transposition reaction proceeded for 30 min at 37 °C on a shaker (300
rpm). Tn5-fragmented DNA was cleaned up using a MinElute PCR puriﬁcation kit
(Qiagen #28004, four reactions per column eluted in 20 µL of EB buffer) and the
resulting 80 µL of eluate was split into 16 PCR reactions (Supplementary Note 2).
PCR was performed using custom HPLC-puriﬁed primers (F: 5′-TAGAGCATG
CACCGGCAAGCAGAAGACGGCATACGAGATNNNNATGTCTCGTGGGC
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TCGGAGATGT-3′, R: 5′-GGCCGAATTCGTCGATCGTCGGCAGCGTCAG
ATGTG-3′, where NNNN corresponds to a random 4 nt i7 barcode sequence) and
NEBNext Ultra II Q5 DNA polymerase master mix (NEB #M0544L). Thermo-
cycler conditions were: 65 °C for 5 min, 98 °C for 30 s, 8 cycles of: 98 °C for 10 s and
65 °C for 90 s. PCR reactions were pooled and cleaned up with a Qiagen MinElute
PCR puriﬁcation kit (two PCR reactions per column eluted in 20 µL of EB buffer)
and run on a 1% agarose E-Gel EX with SYBR Gold II stain (Thermo Fisher
#G402001). Size selection of ATAC-seq fragments was performed by gel excision
using a razor blade to select fragments between 150–500 nt. Gel slabs were pooled
into < 300 mg groups and DNA was puriﬁed using a MinElute Gel Extraction kit
(Qiagen #28604), and eluted in 20 µL of buffer EB per column following modiﬁed
guidelines described in Box 2 of Taiwo et al.40. The resulting size-selected ATAC-
seq fragment library was treated with an anti-mitochondrial DNA CRISPR/Cas9
library following the protocol outlined in Monteﬁori et al. using 10X excess of Cas9
protein (Supplementary Note 3)41. We cleaned up the reaction with a Qiagen
MinElute PCR puriﬁcation kit and split into eight PCR reactions for a second
round of PCR using the same conditions and primers described above. PCR
products were cleaned up using two rounds of AMPure bead selection (0.8X ratio
of beads to input) to size-select against small (<150 nt) fragments, eluted in 40 µL
of dH2O and quantiﬁed using a Qubit dsDNA HS Assay kit (Thermo Fisher
#Q32854).
The pSTARR-seq_human plasmid used for generating the plasmid library
was a gift from Alexander Stark (Addgene plasmid #71509). The linear backbone
used for the subsequent cloning steps was generated by digesting 4 µg of circular
pSTARR-seq_human for 4–6 h with AgeI and SalI restriction enzymes (NEB
#R3552S and R3138S), followed by gel excision under a dark reader
transilluminator (Clare Chemical #DR22A) to extract a linear 3.5 kb fragment
corresponding to the human STARR-seq plasmid backbone. We performed
cloning of the fragment library into the plasmid backbone approximately
following the Methods section from Arnold et al.16. For each library, we
performed 20 individual InFusion HD cloning reactions (Takara Bio #638911)
using a 3.5:1 molar ratio of insert to vector backbone, following manufacturer’s
instructions (Supplementary Note 4). Each group of ﬁve InFusion reactions was
collected and cleaned up using the Qiagen MinElute Enzymatic Reaction cleanup
kit, eluted in 10 µL of dH2O, and transformed into four 20 µL aliquots of MegaX
DH10B T1R electrocompetent bacteria. The bacteria were thawed on ice for 10
min and mixed with eluted DNA (ﬁve InFusion reactions per 100 µL of bacteria).
In total, 22 µL of bacteria/DNA mixture were pipetted into a 0.1 cm
electroporation cuvette (Thermo Fisher Scientiﬁc #P41050) and tapped
repeatedly against a hard surface to remove bubbles. Cuvettes were
electroporated using a Bio-Rad Gene Pulser Xcell Microbial Electroporation
System (Bio-Rad #1652662) using the conditions: 2.0 kV, 200 Ω, 25 µF
(Supplementary Note 5). For high-yield transformations, we observed
electroporation time constants between 4.8 and 5.1 ms. After electroporation,
bacteria were immediately collected in 750 µL pre-warmed SOC media, pooled,
and incubated for 1 h in a 37 °C shaker. After recovery, serial dilutions of
bacteria were plated to estimate the number of clones in the library. Recovered
bacteria were diluted in 2 L of pre-warmed Luria broth and 100 µg/mL of
carbenicillin and grown overnight (8–10 h while shaking). Plasmids were
collected from bacteria using the Plasmid Plus MegaPrep kit (Qiagen #12981)
following manufacturer’s instructions. Plasmid concentration was quantiﬁed
using a Nanodrop One machine (Thermo Scientiﬁc) and diluted to a 3 µg/µL
concentration for subsequent transfection steps. To ensure plasmid library
quality and diversity, a small aliquot of the fragment library was ampliﬁed by
PCR using i5 and i7 primers, run on an Illumina MiSeq machine using the 50-
cycle v2 kit as per manufacturer’s instructions, and aligned to the human
genome to ensure correct complexity and sufﬁcient proportions of reads
within predicted transcriptional regulatory elements (Supplementary Note 6, see
subsequent Methods sections for details on processing of sequencing libraries).
Cell culture and transfections. GM12878 cells were obtained from the Coriell
biorepository and grown in RPMI 1640 Medium with GlutaMAX Supplement
(Thermo Fisher #61870127), 15% fetal bovine serum (Sigma Aldrich #F2442), and
1% pen/strep at a density of between 2 × 105 and 1 × 106 cells/mL with regular
media changes every 2–3 days. Approximately 24 h before transfection, GM12878
cells were split to a density of 4 × 105 cells/mL to ensure the presence of actively
dividing cells for increased transfection efﬁciency. For transfection, cells were
collected by centrifugation for 5 min at 300 g, washed once with pre-warmed PBS,
and collected again for 5 min at 300 g. PBS was aspirated and cell pellets were re-
suspended in Resuspension Buffer R (Thermo Fisher Scientiﬁc #MPK10096) at a
concentration of 7.5 million cells per 100 µL. DNA was added to cells at a con-
centration of 5 µg of plasmid per 1 million cells. In total, we transfected ﬁve
replicates with 120–130M million cells per replicate using 100 µL tips from the
Neon Transfection System at 1200 V with three pulses of 20 ms. Replicate number
was chosen based on other high-throughput reporter assay studies (e.g., Vockley
et al.19 and Tewhey et al.27). Transfected cells were immediately recovered in pre-
warmed GM12878 media without antibiotic and recovered at a density of 1 × 106
cells/mL for 24 h. In parallel, we performed two transfections of GM12878 cells
with a positive control GFP plasmid to assess transfection efﬁciency using the same
conditions.
RNA isolation and cDNA generation. GM12878 cells were collected 24 h post-
transfection, washed twice in pre-chilled PBS (collecting for 5 min at 300 g) and
RNA was puriﬁed using the Qiagen RNEasy Maxi kit (Qiagen #75162) following
manufacturer’s instructions and performing the optional on-column DNase
treatment step (Qiagen #79254). Poly A+RNA was extracted from total RNA using
the Oligotex mRNA Midi kit (Qiagen #70042, two columns per RNA sample), and
any remaining DNA was digested with a second DNase treatment step using Turbo
DNase (Thermo Fisher #AM2238) following manufacturer’s instructions (Sup-
plementary Note 7). Treated mRNA was cleaned up and concentrated using the
Qiagen RNEasy MinElute Cleanup kit (Qiagen #74204). We generated cDNA from
mRNA using Superscript III Reverse Transcriptase (Thermo Fisher #18080085)
with a gene-speciﬁc RT primer located in the 3′ UTR of the sgGFP reporter gene
downstream from the inserted fragments (5′-CAAACTCATCAATGTATCTTAT
CATG-3′). Reverse transcription was performed following manufacturer’s
recommendations except with 2 µg of poly A+mRNA and 1 µL of 12.5 µM primer
per 20 µL reaction, and extension was performed for 60 min at 50 °C (Supple-
mentary Note 8). Reverse transcription reactions were cleaned up using a MinElute
PCR puriﬁcation kit (Qiagen #28106, two reactions per column) and eluted in 15
µL of pre-warmed buffer EB.
Library construction and high-throughput sequencing. We performed a qPCR
to test the number of cycles needed for ampliﬁcation of single-stranded cDNA as
well as input material of plasmid DNA needed such that both reactions had the
same Ct values. We used 1 µL of ssDNA and dilutions of plasmid DNA similar to
the method described by Tewhey et al.27. qPCRs were performed in 10 µL reactions
with all reagents scaled down proportionally from a normal 50 µL PCR reaction (1
µL of DNA, 5 µL of Ultra II Q5 master mix, 0.4 µL of 25 µM primer mix, 0.2 µL of
10X SYBR dye, 3.4 µL of dH2O) with thermocycler conditions: 98 °C for 30 s, 20
cycles of: 98 °C for 10 s, 65 °C for 90 s. We proceeded to perform eight regular 50
µL PCR reactions (each scaled up 5X from the 10 µL PCR reactions) using the same
thermocycler conditions except using the Ct value for the cycle number (F: 5′-
CAAGCAGAAGACGGCATACGAGAT-3′, R: 5′-AATGATACGGCGACCA
CCGAGATCTACAC[X8]TCGTCGGCAGCGTC-3′, “X8” sequence corresponds
to sample barcode, chosen from Illumina Nextera barcode list). PCR reactions were
cleaned up using Qiagen MinElute PCR puriﬁcation kits and balanced for
sequencing using the Kapa Library Quantiﬁcation Kit (Kapa Biosystems #KK4824,
Supplementary Note 9).
Each library batch (ﬁve transfected RNA biological replicates, ﬁve plasmid
controls) was sequenced by the Broad Institute Walk-Up Sequencing Facility on
four ﬂowcells on a NextSeq 500 machine using the 75-cycle kit as per
manufacturer’s instructions for 2 × 37 nt paired-end reads with 2 × 8 nt barcodes.
Fragment data processing and calling active fragment groups. Reads were
labeled by a random 4 nt P7 barcode and an 8 nt P5 barcode for sample ID. Reads
were split into the ten samples (ﬁve plasmid replicates and ﬁve RNA replicates) by
P5 barcode and aligned to the human genome (hg19 assembly) using bowtie2
v2.2.9. Alignment ﬁles were ﬁltered to (i) keep only aligned fragments, (ii) remove
reads mapping to chrM, (iii) select reads passing the -q 30 ﬁlter in samtools, and
(iv) remove reads aligning to the ENCODE hg19 blacklist regions (Supplementary
Note 10). We identiﬁed unique fragments using the bamtobed command in
BEDTools (v2.26.0) and ﬁltered to keep only fragments between 100 and 600 nt. A
diagram illustrating proportion of reads lost to each ﬁlter step is available in
Supplementary Fig. 13.
In analyzing results from HiDRA, we track the abundance of each individual
fragment between the input (plasmid DNA) and output (RNA). We grouped
fragments into “fragment groups” by 75% mutual overlap (bedtools v2.26.0,
intersectBed command), removed redundant fragment groups and summed counts
of all fragments per fragment group. As we detect active fragments by comparing
RNA signal to the non-transfected DNA library, we controlled for the possible
length-dependent biases in transfection efﬁciency of plasmids by splitting fragment
groups into separate bins of 100nt (100–200 nt, 200–300 nt, etc.) and used DEseq2
(v1.10.1) to identify FDR < 0.05 signiﬁcantly up-regulated fragment groups in each
bin42.
Analysis of active HiDRA regions. All overlap and shufﬂe analyses performed
using the BEDTools suite, v2.26.043. Most colors for plots chosen with guidance
from the wesanderson R package (https://github.com/karthik/wesanderson). For
chromatin state annotations, we used the 18-state output model generated by the
Roadmap Epigenomics Consortium6. Active enhancer states were merged from
states #9 and #10 (EnhA1 and EnhA2). ATAC-seq peaks positions were obtained
from Buenrostro et al.21.
Signal tracks: Signal tracks for regulatory activity calculated as (RNA-DNA)/
DNA after adding a pseudocount of 0.1 to both plasmid and RNA samples, so that
fragments with no activity have a regulatory activity value of 0. Signal tracks were
drawn in UCSC Genome browser showing only means (no whiskers) and with 5-
pixel smoothing.
Correlation between RNA samples: We show correlations for fragments selected
by four different cutoffs of minimum RPM. Pearson and Spearman correlations
were calculated on log2-transformed data. Matrix of graphs drawn using layout
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and grid.arrange functions in R from the gridExtra library. Scatterplot between
RNA samples drawn using the hexbinplot function from the hexbin library in R
with xbins= 100.
Proximal vs. distal: TSS regions were deﬁned using the UCSC Genome
Browser’s Table Browser tool for hg19. Distances to nearest annotated TSS were
taken using closestBed tool in the BEDTools2 suite.
TF motif enrichment: We obtained the hg19 TF motif catalog from the
ENCODE project7. We only considered motifs corresponding to transcription
factors expressed in GM12878 (RPKM > 5 using processed GM12878 RNA-seq
data from the Roadmap Epigenomics Consortium). TF motifs in driver elements
were compared against motifs found in shufﬂed driver elements within the same
set of tested tiled regions (regions with at least 10 HiDRA fragments).
Random shufﬂing of driver elements: To assess signiﬁcance of TF motifs,
evolutionary conservation and ﬁne-mapped GWAS SNPs in driver elements, we
shufﬂed the positions of driver elements within tiled regions (genomic segments
with at least 10 HiDRA fragments) using shufﬂeBed with the -incl ﬂag to force
driver elements to be shufﬂed within tiled regions. To assess the signiﬁcance of
enrichment, we performed 1000 shufﬂes of driver elements and calculated z-score
of true driver elements compared to shufﬂed driver elements. The p-value of this
difference was calculated in R from this z-score under a normal distribution (two-
sided) with mean and standard deviation calculated from random shufﬂes.
Activity of HiDRA regions in other tissues: We set a lenient deﬁnition for active
in other tissues as the union of regions annotated in 97 non-GM12878 tissues from
epigenome roadmap predicted with 18-state ChromHMM model. For active
regions we considered states “TssA” (state #1), “TssFlnkU” (state #3), and “EnhA”
(states #9 and 10).
SHARPR-RE activity plots: Tracks were drawn in the UCSC Genome Browser
using “Custom Tracks”. Coloring of individual fragments was performed by setting
maximum and minimum colors (RGB 0,0,0 and RGB 255,255,0, respectively) to
log2(RNA/DNA) values of 3rd lowest and 3rd highest fragments (two strongest
and weakest fragments were removed to avoid strong outliers), and scaling colors
of all other fragments linearly between these extremes. We chose to include only
ChIP-seq bound TF bars for ChIP-seq experiments performed in GM12878 cells by
the ENCODE project and where the motif (green bar) overlapped driver
nucleotides.
Comparison of driver elements vs. MPRA allelic skew: We use allelic skew data
from Supplemental Table S1 from Tewhey et al.27. In total, ~39,500 SNPs were
tested by Tewhey et al.27 for allelic activity, of these 4335 SNPs had enhancer
activity in MPRA fragments containing either allele so that allelic skew can be
calculated. 3291 SNPs remained after using dbSNP142 and the corresponding
RsMergeArch ﬁle to assign coordinates for these SNPs. We used this set of 3291
SNPs to assess the degree of allelic skew inside driver elements.
Comparison of driver elements vs. Sharpr-MPRA activity: We used Sharpr-
MPRA activity scores from the
basepredictions_*_ScaleUpDesign1and2_combinedP.txt ﬁles provided by Ernst
et al.13. We identiﬁed the top Sharpr-MPRA activity score per driver element and
compared these to activity scores for control, shifted elements.
SHARPR-RE identiﬁcation of high-resolution driver elements. See Supple-
mentary Methods for details and more information on SHARPR-RE.
Read mapping and data analysis for allele-speciﬁc activity. We used vcf-
consensus (VCFTools) to mask the hg19 genome assembly by replacing het-
erozygous nucleotides identiﬁed by the Illumina NA12878 Platinum Genome
with N’s. 250 nt paired-end MiSeq reads were trimmed using cutadapt to remove
Illumina primer sequences, mapped to the NA12878-masked hg19 assembly
using bowtie2 v2.2.9 (settings: –end-to-end –phred33 –sensitive -p 7 -N 1 –no-
unal), and ﬁltered using the steps described above for 37 nt reads. As some long
reads have poor quality scores at their 3′ end, we trimmed low quality sequences
(quality value < 38) to reduce the proportion of sequencing errors at SNPs that
could lead to incorrect allelic assignment of fragments. Fragments were then
assigned to a SNP based on genotype at the position. For comparisons of SNP
activity, we only considered fragments with 90% mutual overlap to reduce the
confounding effect of fragments that differ by both allele and position. We also
removed fragments if either end was within 25 nt of a driver element, as in these
cases small differences in end position could artiﬁcally lead to large effects. After
assigning fragment abundances (from high-depth 37 nt PE read sequencing) to
each allele of a SNP, we identiﬁed SNPs with signiﬁcant differential activity
using QuASAR-MPRA. CENTIPEDE SNPs were identiﬁed by Moyerbrailean
et al. using an effect-size cutoff of > 3 or <−3, following the cutoffs used by
Kalita et al.33,34.
Method considerations and detailed information. Additional information and
considerations in applying the method are are provided in the Supplementary Notes.
Data availability
All high-throughput sequencing data generated by this study has been deposited in
NCBI GEO with accession GSE104001. Processed HiDRA plasmid input, RNA output,
activity, as well as active fragments and driver elements can be directly visualized on
the UCSC genome browser at: https://genome.ucsc.edu/cgi-bin/hgTracks?
hgS_doOtherUser=submit&hgS_otherUserNamexinchenw&hgS_otherUserSession-
NameHiDRA_GM12878_092617. These bigWig ﬁles are additionally available at the
NCBI GEO repository (GSE104001). The SHARPR-RE R package is available on
CRAN. All other relevant data supporting the key ﬁndings of this study are available
within the Article and its Supplementary Information ﬁles or from the corresponding
authors upon reasonable request.
Received: 12 January 2018 Accepted: 9 November 2018
References
1. Nord, A. S. et al. Rapid and pervasive changes in genome-wide enhancer usage
during mammalian development. Cell 155, 1521–1531 (2013).
2. Long, H. K., Prescott, S. L. & Wysocka, J. Ever-changing landscapes:
transcriptional enhancers in development and evolution. Cell 167, 1170–1187
(2016).
3. Wamstad, J. A., Wang, X., Demuren, O. O. & Boyer, L. A. Distal enhancers:
new insights into heart development and disease. Trends Cell Biol. 24, 294–302
(2014).
4. Wang, X. et al. Discovery and validation of sub-threshold genome-wide
association study loci using epigenomic signatures. eLife 5, e10557 (2016).
5. Ernst, J. & Kellis, M. Discovery and characterization of chromatin states for
systematic annotation of the human genome. Nat. Biotechnol. 28, 817–825
(2010).
6. Consortium, R. E. et al. Integrative analysis of 111 reference human
epigenomes. Nature 518, 317–330 (2015).
7. ENCODE Project Consortium et al. An integrated encyclopedia of DNA
elements in the human genome. Nature 489, 57–74 (2012).
8. Rada-Iglesias, A. et al. A unique chromatin signature uncovers early
developmental enhancers in humans. Nature 470, 279–283 (2010).
9. Ernst, J. et al. Mapping and analysis of chromatin state dynamics in nine
human cell types. Nature 473, 43–49 (2011).
10. Visel, A., Minovitsky, S., Dubchak, I. & Pennacchio, L. A. VISTA enhancer
browser–a database of tissue-speciﬁc human enhancers. Nucleic Acids Res. 35,
D88–D92 (2007).
11. Taylor, G. C. A., Eskeland, R., Hekimoglu-Balkan, B., Pradeepa, M. M. &
Bickmore, W. A. H4K16 acetylation marks active genes and enhancers of
embryonic stem cells, but does not alter chromatin compaction. Genome Res.
23, 2053–2065 (2013).
12. Pradeepa, M. M. et al. Histone H3 globular domain acetylation identiﬁes a
new class of enhancers. Nat. Genet. 48, 681–686 (2016).
13. Ernst, J. et al. Genome-scale high-resolution mapping of activating and
repressive nucleotides in regulatory regions. Nat. Biotechnol. 34, 1180–1190
(2016).
14. Melnikov, A. et al. Systematic dissection and optimization of inducible
enhancers in human cells using a massively parallel reporter assay. Nat.
Biotechnol. 30, 271–277 (2012).
15. Kwasnieski, J. C., Mogno, I., Myers, C. A., Corbo, J. C. & Cohen, B. A.
Complex effects of nucleotide variants in a mammalian cis-regulatory
element. Proc. Natl Acad. Sci. 109, 19498–19503 (2012).
16. Arnold, C. D. et al. Genome-wide quantitative enhancer activity maps
identiﬁed by STARR-seq. Science 339, 1074–1077 (2013).
17. Vanhille, L. et al. High-throughput and quantitative assessment of enhancer
activity in mammals by CapStarr-seq. Nat. Comms 6, 6905 (2015).
18. Dao, L. T. M. et al. Genome-wide characterization of mammalian promoters
with distal enhancer functions. Nat. Genet. 49, 1073–1081 (2017).
19. Vockley, C. M. et al. Direct GR binding sites potentiate clusters of TF binding
across the human genome. Cell 166, 1269–1281 (2016).
20. Patwardhan, R. P. et al. Massively parallel functional dissection of mammalian
enhancers in vivo. Nat. Biotechnol. 30, 265–270 (2012).
21. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J.
Transposition of native chromatin for fast and sensitive epigenomic proﬁling
of open chromatin, DNA-binding proteins and nucleosome position. Nat.
Methods 10, 1213–1218 (2013).
22. Gillies, S. D., Morrison, S. L., Oi, V. T. & Tonegawa, S. A tissue-speciﬁc
transcription enhancer element is located in the major intron of a rearranged
immunoglobulin heavy chain gene. Cell 33, 717–728 (1983).
23. Huang, Y. et al. cis -Regulatory circuits regulating NEK6 kinase
overexpression in transformed B cells are super-enhancer independent. Cell
Rep. 18, 2918–2931 (2017).
24. Liu, Y. et al. Functional assessment of human enhancer activities using whole-
genome STARR-sequencing. Genome Biol. 18, 219 (2017).
25. Muerdter, F. et al. Resolving systematic errors in widely used enhancer activity
assays in human cells. Nat. Methods 15, 141–149 (2018).
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-07746-1
14 NATURE COMMUNICATIONS |          (2018) 9:5380 | https://doi.org/10.1038/s41467-018-07746-1 | www.nature.com/naturecommunications
26. Barakat, T. S. et al. Functional dissection of the enhancer repertoire in human
embryonic stem cells. Cell. Stem. Cell. 23, 276–288 (2018).
27. Tewhey, R. et al. Direct identiﬁcation of hundreds of expression-modulating
variants using a multiplexed reporter assay. Cell 165, 1519–1529 (2016).
28. Maurano, M. T. et al. systematic localization of common disease-associated
variation in regulatory DNA. Science 337, 1190–1195 (2012).
29. Gusev, A. et al. Partitioning heritability of regulatory and cell-type-speciﬁc
variants across 11 common diseases. Am. J. Hum. Genet. 95, 535–552 (2014).
30. Farh, K. K.-H. et al. Genetic and epigenetic ﬁne mapping of causal
autoimmune disease variants. Nature 518, 337–343 (2014).
31. Jostins, L. et al. Host–microbe interactions have shaped the genetic
architecture of inﬂammatory bowel disease. Nature 491, 119–124 (2012).
32. Hitomi, Y. et al. Identiﬁcation of the functional variant driving ORMDL3 and
GSDMB expression in human chromosome 17q12-21 in primary biliary
cholangitis. Sci. Rep. 7, 2904 (2017).
33. Kalita, C. A. et al. QuASAR-MPRA: accurate allele-speciﬁc analysis for
massively parallel reporter assays. Bioinformatics 34, 787–794 (2018).
34. Moyerbrailean, G. A. et al. Which genetics variants in DNase-Seq footprints
are more likely to alter binding? PLoS. Genet. 12, e1005875 (2016).
35. Inoue, F. et al. A systematic comparison reveals substantial differences in
chromosomal versus episomal encoding of enhancer activity. Genome Res. 27,
38–52 (2017).
36. Murtha, M. et al. FIREWACh: high-throughput functional detection of
transcriptional regulatory modules in mammalian cells. Nat. Methods 11,
559–565 (2014).
37. Zabidi, M. A. et al. Enhancer–core-promoter speciﬁcity separates developmental
and housekeeping gene regulation. Nature 518, 556–559 (2014).
38. Khurana, E. et al. Role of non-coding sequence variants in cancer. Nat. Rev.
Genet. 17, 93–108 (2016).
39. Mifsud, B. et al. Mapping long-range promoter contacts in human cells with
high-resolution capture Hi-C. Nat. Genet. 47, 598–606 (2015).
40. Taiwo, O. et al. Methylome analysis using MeDIP-seq with low DNA
concentrations. Nat. Protoc. 7, 617–636 (2012).
41. Monteﬁori, L. et al. Reducing mitochondrial reads in ATAC-seq using
CRISPR/Cas9. Sci. Rep. 7, 1213 (2017).
42. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
43. Quinlan, A. R. & Hall, I. M. BEDTools: a ﬂexible suite of utilities for
comparing genomic features. Bioinformatics 26, 841–842 (2010).
Acknowledgements
We wish to thank E. Oltz and Y. Huang (Washington U. in St. Louis) for sharing
GM12878 luciferase data; Y. Park for helpful discussions for SHARPR-RE model; R.
Tewhey for helpful discussions and advice on library construction and experimental
protocols; E. Brown for advice on GM12878 transfections; N. Rinaldi, V. Subramanian,
and L. Surface for helpful comments on the paper. M.C. and M.K. were supported by
NIH R01 HG008155, M.C. was supported by a Broad NextGen Award, and M.K. was
supported by R01 GM113708 and U01 HG007610.
Author contributions
X.W., M.C., and M.K. designed the study, X.W., S.G., L.W., and N.S. performed library
construction, X.W. and A.S. performed cell culture, RNA isolation, and sequencing
library construction, L.H. developed the SHARPR-RE methodology, X.W. performed
other computational analyses, X.W., M.C., and M.K. wrote the paper with input from all
authors.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
018-07746-1.
Competing interests: X.W., L.H., M.C., and M.K. have ﬁled a patent on the HiDRA
methodology (ATAC-STARR+ SHARPR-RE). The remaining authors declare no
competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2018
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-07746-1 ARTICLE
NATURE COMMUNICATIONS |          (2018) 9:5380 | https://doi.org/10.1038/s41467-018-07746-1 | www.nature.com/naturecommunications 15
